Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort-Reference-Cited by-同舟云学术

Olaparib maintenance therapy in patients with newly diagnosed advanced ovarian cancer and a BRCA1 and/or BRCA2 mutation: SOLO1 China cohort

Published:2021-01 Issue:1 Volume:160 Page:175-181
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Wu Lingying,Zhu Jianqing,Yin Rutie,Wu Xiaohua,Lou Ge,Wang Jing,Gao Yunong,Kong Beihua,Lu Xin,Zhou Qi,Wang Yueling,Chen Youguo,Lu Weiguo,Li Wei,Cheng Ying,Liu Jihong,Ma Xin,Zhang Jing

Funder

AstraZeneca

Meso Scale Diagnostics

Publisher

Elsevier BV

Subject

Obstetrics and Gynecology,Oncology

Reference21 articles.

1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2019

2. Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Ledermann;Ann Oncol,2013

3. Two decades beyond BRCA1/2: homologous recombination, hereditary cancer risk and a target for ovarian cancer therapy;Walsh;Gynecol Oncol,2015

4. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase;Bryant;Nature,2005

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ovarian cancer derived extracellular vesicles promote the cancer progression and angiogenesis by mediating M2 macrophages polarization;Journal of Ovarian Research;2024-08-24

2. Real-world Study on the Effect of PARPi as Maintenance Therapy on Platinum Sensitivity after First- and Second-line Chemotherapy in Patients with Recurrent High-grade Serous Epithelial Ovarian Cancer;Current Cancer Drug Targets;2024-07

3. PARP inhibitor era in ovarian cancer treatment: a systematic review and meta-analysis of randomized controlled trials;Journal of Ovarian Research;2024-02-26

4. Ovarian cancer derived extracellular vesicles promote the metastasis and angiogenesis by mediating M2 macrophages polarization;2024-02-07

5. Comparison of poly (ADP-ribose) polymerase inhibitors (PARPis) as maintenance therapy for newly-diagnosed and platinum-sensitive recurrent ovarian cancer with BRCA mutational status: a systematic review and network meta-analysis;Expert Review of Anticancer Therapy;2024-01-04